You just read:

DelMar Pharmaceuticals to Host Key Opinion Leader Summit on Glioblastoma Multiforme and the Potential for Treatment with VAL-083

News provided by

DelMar Pharmaceuticals, Inc.

Nov 05, 2019, 08:30 ET